In vivo, CCN2 (connective tissue growth factor) promotes angiogenesis, osteogenesis, tissue repair, and fibrosis, through largely unknown mechanisms. In vitro, CCN2 promotes cell adhesion in a variety of systems via integrins and heparin sulfate proteoglycans (HSPGs). However, the physiological relevance of CCN2-mediated cell adhesion is unknown. Here, we find that HSPGs and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (ERK) mitogenactivated protein kinase cascade are required for adult human dermal fibroblasts to adhere to CCN2. Endogenous CCN2 directly binds fibronectin and the fibronectin receptors integrins ␣4 1 and ␣5 and syndecan 4. Using Ccn2؊/؊ mouse embryonic fibroblasts, we show that loss of endogenous CCN2 results in impaired spreading on fibronectin, delayed ␣-smooth muscle actin stress fiber formation, and reduced ERK and focal adhesion kinase phosphorylation. These results suggest that a physiological role of CCN2 is to potentiate the ability of fibroblasts to spread on fibronectin, which may be important in modulating fibroblast adhesion to the provisional matrix during tissue development and wound healing. These results are consistent with the notion that a principal function of CCN2 is to modulate receptor/ligand interactions in vivo.
INTRODUCTIONHuman skin, the largest organ in the body, acts as a protective barrier between the internal organs and the external environment (Chuong et al., 2002). The barrier function of skin is provided by both the epidermis, which consists of extracellular lipid-like substances and intracellular insoluble keratin (Fuchs and Byrne, 1994), and the dermis, which consists of fibroblasts that produce extracellular matrix (ECM; Kielty and Shuttleworth, 1997).As a response to environmental insults or trauma, or as a consequence of local inflammatory processes, structural damage to skin can occur. The resultant wound-healing response consists of an integrated series of biochemical, immunological, and structural changes culminating in the de novo synthesis of new epithelia, blood vessels, and connective tissue (Werner and Grose, 2003). During this process, fibroblasts synthesize new ECM components, such as collagen and fibronectin (Badylak, 2002). In addition, fibroblasts proliferate and repopulate the wound. These fibroblasts attach to, remodel, and contract the newly synthesized ECM, providing the tensile strength required for the support function of the dermis (Clark, 1985). Thus, understanding the mechanism underlying the ability of fibroblasts to adhere to ECM components such as fibronectin is a necessary prerequisite to understanding how the new dermis and other connective tissues are being synthesized.Connective tissue growth factor (CCN2), a member of the CCN family of matricellular proteins (Bork, 1993;Lau and Lam, 1999;Moussad and Brigstock, 2000;Perbal, 2001;, is a cysteine-rich protein that is secreted via a 37-amino acid signal sequence (Chen et al., 2001b). Secondary sequence structure predictions have suggested that CC...